Skip to main content
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.120
-0.050 (-1.58%)
Nov 13, 2026, 4:00 PM EST - Market closed

X4 Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
31935012514012164
Market Cap Growth
-5.85%179.54%-10.81%16.23%87.36%-38.49%
Enterprise Value
20830568577928
Last Close Price
3.124.0022.0125.1629.7968.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.789.9648.93---
PB Ratio
2.271.885.652.751.631.00
P/TBV Ratio
2.932.19-4.162.131.37

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
12.278.6826.73---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.560.423.531.140.520.62
Net Debt / Equity Ratio
-0.80-0.94-1.08-1.09-1.12-0.65
Net Debt / EBITDA Ratio
1.552.240.170.520.950.56
Net Debt / FCF Ratio
1.452.050.180.581.080.59
Asset Turnover
0.090.160.02---
Inventory Turnover
0.651.58----
Quick Ratio
12.639.853.165.025.505.89
Current Ratio
13.2210.163.415.345.766.27
Return on Equity (ROE)
-80.32%-75.99%-102.26%-161.67%-135.58%-129.28%
Return on Assets (ROA)
-23.13%-22.86%-60.18%-44.38%-40.36%-39.24%
Return on Capital Employed (ROCE)
-33.70%-30.20%-124.50%-86.40%-66.10%-73.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-21.05%-22.64%-29.93%-72.12%-77.78%-137.70%
FCF Yield
-23.89%-24.48%-104.89%-68.84%-63.97%-111.04%
Buyback Yield / Dilution
-660.42%-531.04%-13.08%-179.91%-146.71%-28.25%
SEC Filings: 10-K · 10-Q